Pug this is a very big deal my friend. PixelMags will
Pug this is a very big deal my friend. PixelMags will become one of if not the largest digital content convertor and distributor to multiple platforms. The world is going digital there is no way around it. Not to mention all the companies Pope has been playing musical chairs with, as of late.. Then that one in the 8k. Too many connections here. The interesting thing to me is they are all all about digital content. That content needs to be converted in order to distributed to-each and every platform possible . These other companies are simply lottery tickets to me. Don't get me wrong I loaded and am loading the hell out of them. The true driving force here is PixelMags plain and simple. We are in bed with a very savvy group of innovative minds. PixelMage has a very large foot print with a great reputation among publishers and customers. PixelMags is not lacking either. Well my friend I read 38m in revs for 2015 in the may 2016 8k so that what I'm personally going by. Anything above that I'll accept with open arms. Pug no way in hell am I about to bash this stock. You know this is my baby. With that said due to my position and what friends are holding there is know way that float can possibly be accurate. It doesn't matter to m one way or another. The name PixelMags will be echoing through Wall Street before we know it. The only two questions I have rolling around in my head are. How long will we be on the big board before we encounter a foreword split and what would the share structure be at that time??? This is my retirement and family fund. Holding for a very long time. I'm looking forward to the day in the near future. When I need an extra seven grand I'll tap into the fund and sell a hundred shares. Long money here at PixelMags will go a very long way. Mark that Baby!!!
Thank you for letting me chime in on the board. I have to agree with a poster from earlier. The board cannot be one sided. On the other hand some of the negative posters with nothing to back up their statements. Well they shouldn't be over looked either.
One more very important comment. When investing it is very important that each and every investor dose their own research on their investment. Never let anyone influence your decision either way ever!!! Especially Me!!! These boards are designed to discuss our investment ad finding not to influence investors. Not at all. This go to the lazy ones. Some sites are more truthful than others. Never let pots be a deciding factor Period!!! Do your DD and the. Do it again before investing a dime.
Lock um down Baby!!!
Can't find my reading glasses hopefully not too many errors on the post.
Hope everyone had a great holiday with their family and friends.
O
3
Solaris Power Cells, Inc (SPCL) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
Top 5 Most Recently Viewed Articles
DCHFA Welcomes Dr. Moreiça Allana-Kim Ortega The District of Columbia Housing Finance Agency (DCHFA) has announced an exciting new direction by creating an Office of Strategic Planning and Performance, under the leadership of Dr. Moreiça Allana-Kim Ortega. This new office is aimed at enhancing the effectiveness of the agency by addressing the evolving needs of housing...
Continue Reading
Cboe Achieves Major Milestone in ETF Listings Cboe Global Markets, Inc. (Cboe: CBOE) has achieved a remarkable feat by surpassing 1,000 U.S.-listed exchange-traded funds (ETFs). This notable accomplishment underscores Cboe's position as a premier venue for innovative actively-managed ETFs. The exchange has welcomed an impressive number of 185 new U.S. ETFs this year,...
Continue Reading
Eat Happy Kitchen Expands Retail Presence Nationally In an exciting development for health-conscious shoppers, Eat Happy Kitchen has significantly expanded its reach across the U.S. Nearly 500 stores under the Kroger family umbrella will now feature the woman-owned brand's all-natural line of pasta sauces. This rapid expansion is a testament to the growing demand for...
Continue Reading
Understanding ThreeD Capital's Recent NAV Announcement ThreeD Capital Inc. is a venture capital firm that carefully evaluates its financial standing to provide clarity to its stakeholders. Recently, the company disclosed that its unaudited net asset value (NAV) per share was valued at $0.76 as of December 31, 2024. This announcement reflects ThreeD’s commitment to...
Continue Reading
Simon Quick Advisors Introduces WealthMetrx™ for Tax Efficiency Simon Quick Advisors, a leading independent wealth management firm, has unveiled a new service called WealthMetrx™. This innovative approach aims to offer clients a comprehensive understanding of their tax profile by transforming intricate data into practical insights. With WealthMetrx™, clients can...
Continue Reading
